Register Log-in Investor Type

News

15 Mar 2021

Octopus Renewables Infrastructure reports inaugural annual results

Octopus Renewables Infrastructure (ORIT) announced annual results to 31 December 2020, with the following financial highlights: “ORIT’s IPO took place on 10 December 2019 raising £350m 100% of the net proceeds from IPO are now committed NAV total return of 2.4% over the period since IPO Total shareholder return of 15.9% over the period since […]

15 Mar 2021

QuotedData’s morning briefing 15 March 2021

In QuotedData’s morning briefing 15 March 2021 – International Biotechnology Trust’s (IBT’s) board and its manager, SV Health Investors, announced that Carl Harald Janson has decided to step back from his role as lead manager after seven at the helm. Lead responsibility for portfolio management will transition to Ailsa Craig and Marek Poszepczynski and the board […]

10 Mar 2021

RTW Venture participates in $114m and $36m financing rounds held by Ventyx Biosciences and Visus Therapeutics

RTW Venture Fund (RTW) made two investment announcements yesterday afternoon (9 March) – it participated in the $114m financing round held by Ventyx Biosciences as well as the $36m round held by Visus Therapeutics. The investments are in companies involved in molecule therapeutics and presbyopia-correcting eye drops RTW describes the companies as follows: “Ventyx is a privately-held clinical-stage biotechnology company […]

10 Mar 2021

Chrysalis Investments looks to grow with its active pipeline at around £1bn

Further to Chrysalis Investments’s (CHRY’s) announcement on 8 March 2021 that authority for a new placing programme to issue 600m ordinary and/or C shares had been approved, the company will shortly publish a prospectus containing details on the placing programme. CHRY has raised £470m of capital from shareholders since its launch, which means that the implied […]

10 Mar 2021

F&C proposed final dividend would represent the 50th consecutive annual increase

Global sector company, F&C (FCIT), has reported its annual results to 31 December 2020. The company’s growth and income mandate is carried out through investments in public markets, unquoted investments and private equity. With a market cap of £4.14bn, it is amongst the largest closed-end investment companies and was the first investment trust to launch, back […]

10 Mar 2021

ScotGems’s disappointing performance over 2020 reflects low exposure to China, South Korea and Taiwan

ScotGems (SGEM), the global emerging markets sector trust, reported annual results to 31 December 2020. During 2020, the share price rose by 2.1% and the NAV fell by 1.3%. This compares to a rise in the MSCI emerging markets small cap index of 8.5% and a fall in the MSCI emerging markets ex Asia index […]

10 Mar 2021

QuotedData’s morning briefing 10 March 2021

In QuotedData’s morning briefing 10 March 2021 – EP Global Opportunities (EPG) reported annual results to 31 December 2020, delivering a total NAV return of -1.3% and a total share price return of -5.6%. EPG has adopted a cautious stance on its investment outlook, with a defensively positioned equity portfolio. At the year-end, 13% of net […]

08 Mar 2021

D9 Digital Infrastructure prospectus published

D9 Digital Infrastructure prospectus published D9 Digital Infrastructure has published a prospectus in relation to its initial public offering (IPO). As promised, here is a link to the prospectus, which was published today. As the prospectus makes clear, access to the issue is subject to some geographical restrictions. Make sure you read these. As always, we aren’t recommending […]

08 Mar 2021

Ashoka India Equity beats benchmark and says majority of population likely to be vaccinated by the year-end

Ashoka India Equity (AIE) performed well over its interim results to 31 December 2020, with the share price and NAV delivering total returns of 39.1% and 28.6%. This compares with the benchmark MSCI India IMI index’s 27.1% return. Returns led by Infosys and Coforge while Bharti Airtel detracts Infosys, which had an ending weight in the portfolio of 7.5% at the […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…